Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20230364Phase 3Completed
A Phase 3 trial of follitropin alfa in anovulation, polycystic ovary syndrome (PCOS), female infertility, hypogonadotropic hypogonadism (HH), sponsored by Livzon Monoclonal Antibody. Started Feb 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20230364.